Related by context. Frequent words. (Click for all words.) 67 Receives Orphan Drug Designation 65 Initiates Phase II 65 Recombinant Human 65 Monoclonal Antibody 65 epothilone 65 Drug Candidate 64 liposomal formulation 64 Factor VIIa 64 polymerase inhibitor 64 Small Molecule 64 Initiate Phase 63 Initiates Phase 63 FDA Accepts 63 Dasatinib 63 Presents Positive 62 Phase III Clinical Trial 62 TLR9 agonist 62 Preclinical Data 62 proteasome inhibitor 61 MEK inhibitor 61 fusion inhibitor 61 Inhibitor 61 Ambrisentan 61 TELINTRA 61 PEG SN# 60 Completes Enrollment 60 RNAi Therapeutics 60 Patent Covering 60 drug conjugate 60 Erlotinib 60 Mipomersen 59 Pivotal Phase III 59 Pivotal Phase 59 Oligonucleotide 59 humanized antibody 59 FDA Clears 59 GHRH 59 KRN# 59 DermaVir 59 PDE4 58 Antisense 58 radiolabeled 58 Panzem R 58 subcutaneous formulation 58 Analogs 58 Phase Ib II 58 selectively inhibits 58 FLT3 58 TH# [003] 58 Nexavar ® 58 elotuzumab 57 EP# [003] 57 Roflumilast 57 mTOR inhibitor 57 eniluracil 57 Nucleic Acid 57 poly ADP ribose polymerase 57 Vilazodone 57 PLK1 SNALP 57 IMC #B 57 Guanilib 57 nucleoside reverse transcriptase inhibitor 57 Tesetaxel 57 atacicept 57 Antifungal 57 Protease 57 ALN TTR 57 Octreotide 57 amrubicin 57 Avanafil 57 administered subcutaneously 57 selective inhibitor 56 selective inhibition 56 luteinizing hormone releasing 56 anticancer agent 56 FM VP4 56 proteasome inhibitors 56 FK# 56 vascular disrupting agent 56 Denufosol 56 ALN TTR# 56 Inhibitors 56 Orphan Drug Status 56 Announces FDA Clearance 56 Daclizumab 56 Carfilzomib 56 HCV protease inhibitor 56 Cancer Vaccines 56 intravenously administered 56 PHARM 56 integrase inhibitor 56 Lamivudine 56 Oxaliplatin 56 Tacrolimus 56 registrational trial 56 Bicifadine 56 ImmunoCellular Therapeutics 56 pegylated 56 JAK1 56 II Clinical Trial 56 CORT #